Sutro Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	153.73	67.77	61.88	42.72	42.74	38.42	51.74	59.73
Revenue Growth (YoY)	126.84%	9.52%	44.84%	-0.03%	11.24%	-25.75%	-13.38%	-
Gross Profit	153.73	67.77	61.88	42.72	42.74	38.42	51.74	59.73
Selling, General & Admin	62.58	59.54	56	36.82	32.59	21.38	16.37	14.82
Research & Development	180.43	137.17	104.4	76.96	65.61	54.26	54.64	43.55
Operating Expenses	243.01	196.72	160.4	113.78	98.2	75.64	71.01	58.37
Operating Income	-89.28	-128.94	-98.52	-71.06	-55.47	-37.22	-19.27	1.36
Interest Expense / Income	11.18	3.35	3.14	3.97	4.35	-0.29	0.69	0
Other Expense / Income	-11.86	-15.59	3.88	-43.01	-4.07	-1.62	-0.27	-0.34
Pretax Income	-88.6	-116.7	-105.54	-32.03	-55.74	-35.32	-19.69	1.7
Income Tax	18.19	2.5	0	0.1	0	0	0	0
Net Income	-106.79	-119.2	-105.54	-32.13	-55.74	-35.32	-19.69	1.7
Shares Outstanding (Basic)	60	51	46	33	23	6	0	0
Shares Outstanding (Diluted)	60	51	46	33	23	6	0	0
Shares Change	18.57%	10.02%	41.58%	41.88%	298.66%	1185.62%	9.86%	-
EPS (Basic)	-1.78	-2.35	-2.29	-0.99	-2.43	-6.13	-43.95	-
EPS (Diluted)	-1.78	-2.35	-2.29	-0.99	-2.43	-6.13	-43.95	-
Free Cash Flow	-115.93	-4.31	-97	-74.93	-68.5	11.13	-40.39	-17.53
Free Cash Flow Per Share	-1.93	-0.09	-2.10	-2.30	-2.98	1.93	-90.17	-43.00
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-58.07%	-190.26%	-159.22%	-166.32%	-129.79%	-96.89%	-37.25%	2.28%
Profit Margin	-69.47%	-175.89%	-170.55%	-75.20%	-130.44%	-91.93%	-38.05%	2.85%
Free Cash Flow Margin	-75.41%	-6.36%	-156.76%	-175.39%	-160.30%	28.96%	-78.06%	-29.35%
EBITDA	-66.98	-105.07	-92.63	-23.75	-46.62	-31.07	-14.01	7.36
EBITDA Margin	-43.57%	-155.03%	-149.69%	-55.60%	-109.08%	-80.87%	-27.08%	12.33%
Depreciation & Amortization	10.44	8.29	9.77	4.3	4.78	4.54	4.99	5.66
EBIT	-77.42	-113.36	-102.4	-28.05	-51.39	-35.61	-19	1.7
EBIT Margin	-50.36%	-167.26%	-165.48%	-65.66%	-120.26%	-92.68%	-36.72%	2.85%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).